###### Article summary

Article focus
=============

-   In patients with ST-elevation myocardial infarction (STEMI), rapid reperfusion therapy when every minute counts is a key factor for successful treatment and outcome but continues to be administered too late.

-   We hypothesised that (1) a detailed identification of system time delays, followed by (2) personal feedback on time delays to staff involved in the acute care of STEMI patients and (3) targeted reorganisation of logistics, would (4) lead to a reduction in system time delays in an STEMI network characterised by a high frequency of direct admission by ambulance to the catheter laboratory.

-   The aim was to identify, evaluate and improve system time delays in an STEMI network using an action research approach.

Key messages
============

-   Identification of system time delays, collaborative discussions and feedback to staff involved in STEMI care resulted in three tailored reorganisations: (1) emergency medical services personnel prioritising ECG recording, (2) central evaluation of ECG in all patients with suspected STEMI and (3) starting percutaneous coronary intervention (PCI) procedure with two of three PCI team members on site.

-   Multiple key time measurements before and after the intervention showed that the total time from diagnosis to a patent artery decreased from 95 to 84 min. Though not statistically significant, it is an important reduction when it happens to reach a successful outcome for STEMI patients.

-   Action research can be used as an effective tool to identify time delays in an STEMI network and contribute to awareness of delay factors and facilitate reorganisation of logistics. Together with continuous feedback on time delays that stimulate reflective clinical behaviour, system delay times can be reduced substantially.

Strengths and limitations of this study
=======================================

-   The study\'s multistage action research approach allowed interpersonal involvement and awareness and a detailed exploration---as well as improvement---of system time delays, not possible when focusing on reorganisation of logistics only.

-   This was a single centre study including a relatively small number of patients for the multiple time point measurements. Involvement and interventions at the emergency room could have been more focused. Multiple interventions make it difficult to draw firm conclusions about which single intervention had the largest effect on reduction of the delay time.

Introduction {#s1}
============

In patients with ST-elevation myocardial infarction (STEMI), shorter time from the time from first medical contact (FMC) to a patent artery has been associated with lower mortality[@R1] and lower risk for re-admissions due to heart failure.[@R2] Though rapid coronary reperfusion reduces mortality in patients with STEMI, reperfusion therapy continues to be administered too late.[@R3] Hospitals that have short door-to-balloon time have adopted strategies such as prehospital ECGs to activate the catheter laboratory (cath-lab), an attending cardiologist always on site, explicit goals, continuous feedback on time delays and an interdisciplinary collaboration throughout the process.[@R4] Ward *et al* [@R5] identified periods during the sequence of events where time delays were unacceptable (mainly ECG to exit emergency room (ER) and sheath to balloon inflation) and they made changes in their local guidelines for STEMI that reduced door-to-balloon times from 136 to 82 min. Other investigators have been able to achieve similar improvements simply by monitoring performance on door-to-balloon times without changing the STEMI strategy.[@R6] These two studies identified the time delays retrospectively and studied patients arriving at the ER at the Percutaneous Coronary Intervention (PCI) Centre. The aim of the present study was to identify and evaluate system delay times in an STEMI network using action research. We hypothesised that identification of time delays, followed by targeted reorganisation of logistics and personal feedback on time delays to staff involved in the care of STEMI patients, would lead to a reduction in system delay time in an STEMI network characterised by a high frequency of direct admission by ambulance to the cath-lab.

Methods {#s2}
=======

Setting {#s2a}
-------

In the county of Östergötland with a population of 430 000 people, there are three hospitals. The Heart Centre at the University Hospital of Linköping, the only one with cath-lab facilities, is located in the centre of the county with a distance to the two referring hospitals of 45 km and with a distance to the outmost border of the county of 100 km. The average transportation time for STEMI patients admitted by the Emergency Medical Services (EMS) in the county is 30 min, with approximately 70% arriving in ambulances all staffed with nurses. Communication with the Heart Centre is by phone as well as through an on-board on-line computer system. Since 2005, the Heart Centre has adopted a strategy of providing primary PCI for all patients with STEMI in the county. Patients who present with symptoms of acute coronary syndrome and have an ECG recorded by the EMS that shows ST-elevation and extensive anterior ST-depression indicative of posterior STEMI or Bundle Branch Block are sent directly to the cath-lab with the intention of employing primary PCI. In case the patient is admitted to the ER, the emergency physician contacts the cardiologist on call at the Heart Centre when STEMI is suspected.

Study design {#s2b}
------------

The study was carried out between 2006 and 2011 and designed as a multistage action research project. Three study phases were used: exploration (preintervention phase), tailored intervention and evaluation (postintervention phase). The study involved: (1) collaborative discussions and participant observations to identify system delay, (2) multiple time point measurements before the intervention, (3) awareness of the delay factors, (4) reorganisation of logistics and (5) multiple time point measurements after the intervention ([figure 1](#BMJOPEN2013003493F1){ref-type="fig"}).

![Timeline for the study.](bmjopen2013003493f01){#BMJOPEN2013003493F1}

### Action research {#s2b1}

Action research is characterised by participation and begins with recognition of social and institutional problems and need for change,[@R7] focusing on a concern for doing research with, for and by people, rather than on them. There is collaboration between researchers and study participants in the process of defining the problem,[@R8] the selection of an approach and research methods, the analysis of the data and the use to which the findings are to be put. The aim is to produce not only knowledge but also action, as well as to develop processes of collaboration and dialogue and to raise awareness of a joint problem. Action research is an iterative process in which researchers and practitioners act together in the context of an identified problem to discover and effect positive change within a mutually acceptable ethical framework[@R9] ([box 1](#bx1){ref-type="boxed-text"}). Box 1What are the key features of action research?The key features of action research include its collaborative nature, its democratic approach to power and education in the research process, and its emphasis on taking action on an issue. The extensive collaboration between researchers and study participants (eg, staff) in action research must extend across each stage of research, from identifying the problem to disseminating the results. This collaboration entails shared control of the agenda and also involves reciprocal education to improve researchers' and research participants' understanding of one another\'s positions and contributions. Finally, the study must blend scientific inquiry with social action by creating knowledge that is relevant to the research participants' needs and interests.

Preintervention phase {#s2c}
---------------------

The preintervention phase was carried out between 25 November 2006 and 14 March 2007 and began with identification and measurement of multiple time points for a total of 67 consecutive patients with STEMI admitted for primary PCI at the Heart Centre ([box 2](#bx2){ref-type="boxed-text"}). To be included in the study, patients had to have: (1) symptom onset outside hospital, (2) ST-elevation or extensive ST-depression indicative of posterior infarction or bundle branch block on the ECG, (3) a final diagnosis of myocardial infarction (I21 to I23, ICD 10), (4) treatment with primary PCI at the Heart Centre and (5) living in the catchment area of the Heart Centre. Patient delay was defined as the time from symptom onset to FMC. FMC was defined as the time when the patient called the EMS for those patients admitted directly to the cath-lab and for other patients it was the time when the patient arrived at the ER. Time to decision was defined as the time from ECG recording to the time when the cardiologist on call decided on primary PCI. Cath-lab time was time from arrival at the cath-lab to balloon inflation, activation of the thrombectomy device or thrombolysis in myocardial infarction (TIMI) 2--3 flow in the infarct-related artery (IRA), whichever came first. System delay time was defined as the time from FMC to balloon inflation/thrombectomy or visualisation of TIMI 2--3 flow in the IRA, whichever was achieved first ([figure 2](#BMJOPEN2013003493F2){ref-type="fig"}).

![Delays from symptom onset to primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Numbers indicate median time (minutes). FMC, First Medical Contact; PPCI, primary percutaneous coronary intervention; TIMI3, thrombolysis in myocardial infarction grade 3 coronary flow, that is, normal flow.](bmjopen2013003493f02){#BMJOPEN2013003493F2}

###### Multiple time point measurements

-   Symptom awareness

-   Contact with the emergency medical services

-   Arrival of ambulance at the patient\'s location

-   Transmission of ECG to the Coronary Care Unit (CCU) at the Heart Centre

-   Start of transfer of patient to the Heart Centre

-   Time of contact with cardiologist on call at the Heart Centre

-   Decision to perform percutaneous coronary intervention (PCI)

-   Contact with PCI team

-   Arrival of the patient at ambulance entrance at the Heart Centre

-   Arrival of the patient at the CCU and/or PCI unit

-   Administration of local anaesthesia as a marker for start of PCI

-   Balloon inflation or activation of a thrombectomy device, whichever occurs first

-   Time of thrombolysis in myocardial infarction 2--3 flow in the infarct-related artery

-   Last performed angiogram as a marker for end of PCI

**Among patients arriving at the emergency room, additional time points measured were** Arrival of the patient at the emergency roomRecording of an ECGDetection of ST-segment elevation myocardial infarctionDecision to transfer patient for primary PCIArrival of ambulance at the referring hospital with no cath-lab on siteAmbulance leaving the referring hospital

There was extensive collaboration between researchers and staff at the Heart Centre and the EMS in order to identify areas of time delay that we believed could be influenced through targeted reorganisation of logistics. These areas were identified through collaborative analysis of the measured delay times and through participant observations at the EMS, the coronary care unit (CCU) and the cath-lab at the Heart Centre. Furthermore, several discussions with interventionists, nurses, representatives from the EMS, staff at the ER and leading physicians, including those at the spoke hospitals participating in the treatment of STEMI patients, were carried out. Discussions and participant observations revealed first and foremost that recording and transmitting an ECG was not the first thing carried out when approaching a patient with suspected STEMI. Moreover, in the preintervention phase, ECG recordings from ambulances in the catchment area of the three hospitals in the county of Östergötland were transmitted and analysed at the CCU at the respective hospital. Finally, the PCI team (one interventionist and two nurses) did not start the procedure until all three members of the PCI team were in place at the cath-lab.

Tailored interventions {#s2d}
----------------------

The interventions were carried out between 2008 and 2010 and involved interpersonal interventions with awareness of the delay factor, and system interventions with reorganisation of logistics. In addition to the targeted interventions and outside the study, the board of the Heart Centre decided to have an attending cardiologist on site 24 h/7 days a week from 14 January 2007 ([figure 1](#BMJOPEN2013003493F1){ref-type="fig"}).

### Awareness of the delay factor {#s2d1}

Staff members involved in the treatment of STEMI patients were continuously reminded of the delay factors in the outcome of STEMI. The 'time is muscle' principle was highlighted at meetings and clinical discussions involving the STEMI population. In addition, personal written feedback on time delays for every STEMI patient (de-identified) was sent to physicians and EMS personnel involved in the treatment. Individuals were encouraged to contact the principal investigator of the study to further discuss the delay times (see online supplementary appendix 1).

### Reorganisation of logistics {#s2d2}

The following areas of targeted refining of logistics were carried out: (1) EMS personnel were instructed to prioritise ECG recording, (2) evaluation of the ECG in all patients with suspected STEMI in the county of Östergötland was made centrally at the CCU at the Heart Centre and (3) the PCI team was to start the PCI procedure as soon as two of the three members were on site.

### Postintervention phase {#s2d3}

After refining the logistics and training personnel in the new procedures, the records for another 89 consecutive patients with STEMI (postintervention group) treated between 1 October 2010 and 17 February 2011 were reviewed for time delays in a manner similar to that used for the preintervention group.

Statistical analysis {#s2e}
--------------------

Data were analysed with SPSS software, V.20.0 (SPSS, Chicago, Illinois, USA). Continuous variables were reported as mean ± SD or median (25th--75th centile) as appropriate. For normally distributed variables, the two-tailed Student t test and for non-normally distributed variables the Mann-Whitney U test was used to verify statistical differences between the preintervention and postintervention groups. Categorical variables were expressed as counts (percentage). Statistical significance was assessed with the χ^2^ or Fisher\'s exact tests.

Results {#s3}
=======

The mean age of patients in the study was 67 years and one-third of the patients were women. There were no significant differences in baseline characteristics between the preintervention and postintervention groups ([table 1](#BMJOPEN2013003493TB1){ref-type="table"}). Sixty-seven per cent of patients were admitted directly to the cath-lab by the EMS system. The patient delay remained unchanged during the preintervention and postintervention phases ([table 2](#BMJOPEN2013003493TB2){ref-type="table"}). Important delay times for patients admitted directly to the cath-lab are given separately in the lower half of [table 2](#BMJOPEN2013003493TB2){ref-type="table"}.

###### 

Baseline characteristics

  ----------------------------------------------------------------------------------
                                    Preintervention\   Postintervention\   p Value
                                    N=(67)             N=(89)              
  --------------------------------- ------------------ ------------------- ---------
  Age (years (SD))                  68.0 (12.6)        66.7 (12.9)         0.52

  Women                             21 (31.3)          26 (29.2)           0.77

  Risk factors                                                             

   Diabetes mellitus                8 (11.9)           14 (15.7)           0.50

   Hypertension                     27 (40.3)          30 (33.7)           0.40

   Current smoker                   23 (34.3)          24 (27.0)           0.32

   Hyperlipidaemia                  14 (20.9)          27 (30.3)           0.18

   Previous myocardial infarction   9 (13.4)           18 (20.2)           0.27

   Previous revascularisation       8 (11.9)           18 (20.2)           0.17

    PCI                             7 (10.4)           16 (18.0)           0.19

    CABG                            1 (1.5)            5 (5.6)             0.24

  Clinical presentation                                                    

   Cardiogenic shock                1 (1.5)            4 (4.5)             0.39

   Presentation off-hours           45 (67.2)          53 (59.6)           0.33

   Direct admission to cath-lab     45 (67.2)          59 (66.3)           0.91
  ----------------------------------------------------------------------------------

Data are presented as counts (percentage) if not otherwise indicated.

CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.

###### 

Time delays

                                                 Preintervention N=(67)   Postintervention N=(89)   p Value
  ---------------------------------------------- ------------------------ ------------------------- ---------
  Time delays, median, min (IQR)                                                                    
   Symptom to FMC                                70 (32--173)             76 (34--154)              0.77
   FMC to ECG                                    18 (10--28)              18 (11--30)               0.85
   Ambulance arrival to departure from patient   20 (12--30)              17 (13--22)               0.18
   FMC to cath-lab                               84 (68--115)             72 (62--102)              0.07
   FMC to balloon                                112 (98--148)            108 (91--150)             0.41
   FMC to balloon or TIMI 2--3                   110 (95--141)            104 (86--138)             0.30
   ECG to decision for primary PCI               9 (2--16)                3 (1--8)                  0.004
   ECG to cath-lab                               66 (53--85)              55 (43--70)               0.02
   ECG to balloon                                96 (82--118)             90 (76--116)              0.28
   ECG to balloon or TIMI 2--3                   95 (76--114)             84 (68--110)              0.19
   Arrival at cath-lab to balloon                28 (22--35)              32 (24--42)               0.03
   Arrival at cath-lab to balloon or TIMI 2--3   22 (17--30)              24 (19--34)               0.06
  *Patients with direct admission to cath-lab*   N=(45)                   N=(59)                    
  Symptom to FMC                                 55 (24--138)             74 (27--144)              0.70
  FMC to balloon or TIMI 2--3                    104 (83--130)            102 (86--129)             0.82
  FMC to ECG                                     18 (15--29)              18 (11--30)               0.88
  ECG to decision for primary PCI                4 (1--11)                2 (1--5)                  0.19
  ECG to cath-lab                                56 (43--68)              53 (42--64)               0.30
  Arrival at cath-lab to balloon or TIMI 2--3    25 (13--35)              24 (19--31)               0.86

Key time measurements. Data are presented as median time in minutes. TIMI 2--3 flow is defined as a patent coronary artery.

FMC, first medical contact; PCI, percutaneous coronary intervention; TIMI, thrombolysis in myocardial infarction.

The system delay time decreased from 110 to 104 min, and time from FMC to cath-lab arrival from 84 to 72 min; however, these changes did not reach statistical significance. The time from FMC to ECG recording remained unchanged after the intervention, 18 min both before and after. There was a 3 min reduction in time from ambulance arrival at the scene to departure to the Heart Centre, but this too was not statistically significant. The time delay from ECG recording to decision for primary PCI was reduced from 9 to 3 min, p=0.004, which was also reflected in the 11 min shorter time to arrival in the cath-lab after diagnosis of STEMI, p=0.02. On the other hand, after changing the procedure so that only two of three members had to be on site to start the PCI procedure, there was an increase in the cath-lab time in the postintervention phase from 22 to 24 min (ns; [table 2](#BMJOPEN2013003493TB2){ref-type="table"}). The total time from diagnosis to a patent artery, though not statistically significant, decreased from 95 to 84 min ([table 2](#BMJOPEN2013003493TB2){ref-type="table"}).

The proportion of patients receiving GIIb/IIIa inhibitors (in all cases abciximab) before arrival at the cath-lab was significantly higher in the preintervention phase, which was reflected in a more frequent identification of a patent artery at the first angiogram, 43% vs 29%, ns. There were no differences in the IRA between the groups ([table 3](#BMJOPEN2013003493TB3){ref-type="table"}). A separate analysis comparing patients in the preintervention group before and after 14 January 2007 (ie, when the cardiologist on call was on site 24/7) revealed a decrease in decision time from 13 to 6 min, ns.

###### 

Angiographic data

  -------------------------------------------------------------------------------
                                 Preintervention\   Postintervention\   p Value
                                 N=(67)             N=(89)              
  ------------------------------ ------------------ ------------------- ---------
  Radial puncture                0 (0)              53 (59.6)           0.0005

  Abciximab before cath-lab      50 (74.6)          44 (49.4)           0.001

  Abciximab prehospital          45 (67.2)          44 (49.4)           0.03

  Infarct-related artery                                                

   LAD                           29 (43.3)          43 (48.3)           0.53

   Cx                            9 (13.4)           11 (12.2)           0.84

   RCA                           28 (41.8)          33 (37.1)           0.55

   Left main                     0 (0)              1 (1.1)             1.0

   Vein graft                    0 (0)              1 (1.1)             1.0

  TIMI flow at first angiogram                                          

   TIMI 0--1                     38 (56.7)          63 (70.8)           0.07

   TIMI 2--3                     29 (43.3)          26 (29.2)           0.07
  -------------------------------------------------------------------------------

Data are presented as counts (percentage).TIMI 0--1 is defined as an occluded artery. TIMI 2--3 is defined as a patent artery.

Cx, circumflex artery; LAD, left anterior descending artery; RCA, right coronary artery; TIMI, thrombolysis in myocardial infarction.

During the preintervention phase, all patients were catheterised by the femoral route. In the postintervention phase, radial puncture became more and more the standard access site for primary PCI. Analysis of the puncture site irrespective of the inclusion period revealed preparation time (defined as the time from arrival at the cath-lab to infiltration of the access site with anaesthetics) and cath-lab time to be 10 and 23 min for the femoral route and 12 and 24 min for the radial route, respectively, ns. A separate comparison of patients with an occluded IRA and those with a patent IRA at the first angiogram irrespective of the time period revealed a shorter time from arrival at the cath-lab to balloon inflation for those with occluded IRA, 26 vs 32 min, p=0.006.

Discussion {#s4}
==========

By co-operative discussions with personnel involved in the STEMI care process, we identified points of time delay occurring during the period when patients with STEMI were being cared for. Through the reorganisation of logistics and continuous feedback on time delays in our STEMI network with an already high frequency of direct admission by ambulance to the cath-lab, we were able to reduce the time from diagnosis of STEMI to arrival at the cath-lab by 11 min. Even though a reduction of 11 min between diagnosis of STEMI and a patent artery might seem small, de Luca *et al*[@R10] showed in their meta-analysis that each 30 min of delay was associated with a relative risk for 1-year mortality of 1.075. The time from FMC to arrival at the cath-lab and from FMC to a patent artery was reduced by 12 and 6 min, respectively; however, this reduction was not statistically significant. The indication of initial improvement was, at least partially, hampered by an increased cath-lab time. The time from arrival at the cath-lab to balloon inflation, activation of the thrombectomy device or demonstration of a patent IRA, whichever came first, increased from 22 to 24 min during the study period. The cath-lab team was ready to accept the patient and start PCI procedure with two of three members on site, which probably contributed to the reduced time from diagnosis to cath-lab arrival. On the other hand, this may have made the procedure less effective during the initiation of this procedure if only two rather than three had been present. The preferred access site during the postintervention phase was the right radial artery. Studies have shown a slightly longer preparation and door-to-balloon time for the radial approach as compared with the femoral approach.[@R11] In our study, preparation-time and cath-lab delay time appeared to be 1--2 min longer for radial access than for femoral access.

Strategies to reduce system delay time {#s4a}
--------------------------------------

Most studies have focused on door-to-balloon times,[@R12] but this approach fails to take into account other reasons for system delay.[@R13] We focused on improvement of the more robust and objective system delay time, specifically the time to decision by the cardiologist on call and the time to arrival at the cath-lab. Several strategies that reduce system delay time were used in our study including central evaluation of the ECG[@R14] and real-time data feedback.[@R15] We noted that the regularly given feedback resulted in intense, collaborative discussions among caregivers. Reflection on the individual\'s actions is seen as necessary for continuing professional development,[@R16] and studies have suggested that increasing reflection on medical problems could improve clinical competence.[@R17] Most of the reduction in system delay time in our study was achieved by shortening the time to decision by 6 min. The probable cause of this improvement was the central evaluation of ECG and having an attending cardiologist on site. Independent of our study, the board of the Heart Centre decided to have an attending cardiologist on site 24/7 from 14 January 2007 to the present. The impact of this strategy on system delay time has been questioned.[@R18] Field triage by the EMS with prehospital ECG and activation of the cath-lab team and the bypassing of local hospitals by admitting STEMI patients directly to the cath-lab has a documented impact on reducing system delay time.[@R19] This strategy, which is common in Scandinavia,[@R20] was used in 67% of our patients. During the study period, there was a significant reduction in the use of GIIb/IIIa administration upstream, probably caused by the results of the FINESSE study.[@R21] This was reflected in a trend to less frequent patent IRA at the first angiogram. The time between arrival at the cath-lab to balloon inflation was 6 min longer for patients with a patent rather than occluded IRA at the first angiogram. This could be interpreted as indicating that PCI operators do not rush the procedure once they identify a patent IRA.

System delay time in perspective {#s4b}
--------------------------------

The cath-lab delay time, in line with other studies,[@R1] was not reduced. However, shorter time delays in the cath-lab have been reported from centres with \>700 primary PCI annually.[@R22] The European Society of Cardiology states that primary PCI (wire passage) should be performed within 90 min after FMC in all cases except in patients presenting early with large area at risk where PCI should be performed within 60 min.[@R23] In patients admitted from the ambulance directly to the cath-lab irrespective of the time period, the time from EMS arrival at the scene to a patent artery was 91 min in our study. These delay times are almost identical to the time delays reported by Terkelsen *et al*.[@R24] Moreover, time delays observed in the present study seem to be similar to those reported in other studies.[@R25; @R26; @R27; @R28; @R29; @R30] Future research and strategy implementation should probably focus on earlier diagnosis of STEMI and increasing public awareness of STEMI to reduce treatment delay time in STEMI.[@R31]

Limitations of the study {#s4c}
------------------------

This was a single centre study including a small number of patients for the multiple time point measurements. We cannot exclude the possibility that a larger study population would have shown a different result. Ideally, we would randomise the patients to different strategies, but this is not possible for obvious reasons. However, because the system delay factor embraces a tension between local solutions at the Department of Cardiology and transferable knowledge at the EMS and the ER, action research was considered suitable in order to make the results more generally applicable. Interventions at the ER could have been more focused since we retrospectively noticed that one-third of the STEMI patients included in the study arrived directly in the ER. Lastly, multiple interventions make it difficult to draw firm conclusions about which single intervention had the largest effect on reduction of the delay time.

Conclusion {#s5}
==========

Action research can be used as an effective tool to identify time delays in an STEMI network and contribute to awareness of delay factors and facilitate reorganisation of logistics. Together with continuous feedback on time delays that stimulate reflective clinical behaviour, several system delay times could be reduced significantly.
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